| Name | Title | Contact Details |
|---|
Keen.com is a website that connects people with psychics.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Opteamix is a digital technology consulting firm that is built on reimagining the technology of tomorrow, today! We present you with state-of-the-art innovative business IT solutions by combining the power of cutting-edge technologies and traditional s...
Ramco Systems offers cloud, mobile, chatbot and Voice-ready ERP, HR, Global Payroll, Logistics, EAM and Aviation M&E MRO Software. We build Active ERP infused with AI and ML.